MAP2K7 and melanoma: Similar G1-phase growth arrest results have been observed with allosteric MEK inhibitors, such as U0126, PD0325901 and AZD6244, suggesting that inhibition of the MAPK pathway in melanoma is largely cytostatic (Smalley et al, 2006; Solit et al, 2006; Haass et al, 2008).